ctrl K

Janux Therapeutics Inc. (JANX)

NASDAQ: JANX · Real-Time Price · USD

32.10

-1.10 (-3.31%)

At close: May 01, 2025, 3:59 PM

33.20

3.41%

Pre-market: May 02, 2025, 08:24 AM EDT

Janux Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	430.61M	19.2M	51.43M	35.58M	7.81M	658K
Short-Term Investments	594.57M	324.82M	275.59M	339.38M	n/a	n/a
Long-Term Investments	n/a	n/a	816K	816K	n/a	n/a
Other Long-Term Assets	3.7M	3.33M	1.39M	392K	-155K	-21K
Receivables	n/a	n/a	n/a	n/a	8M	n/a
Inventory	n/a	n/a	-700K	-200K	n/a	n/a
Other Current Assets	n/a	5.21M	5.42M	2.05M	249K	n/a
Total Current Assets	1.03B	349.24M	332.44M	377.02M	16.06M	658K
Property-Plant & Equipment	24.15M	27.84M	29.36M	1.6M	155K	21K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	27.85M	31.17M	31.57M	2.81M	155K	21K
Total Assets	1.06B	380.41M	364.01M	379.82M	16.22M	679K
Account Payables	4.03M	2.42M	2.16M	2.46M	428K	267K
Deferred Revenue	n/a	1.71M	5.41M	5.16M	1.95M	n/a
Short-Term Debt	1.75M	n/a	763K	194K	n/a	4M
Other Current Liabilities	11.68M	3.3M	4.75M	3.62M	517K	278K
Total Current Liabilities	17.46M	13.03M	16.51M	12.8M	3.18M	4.63M
Long-Term Debt	n/a	n/a	24.54M	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	-24.54M	n/a	21.62M	n/a
Total Long-Term Liabilities	21.28M	23.02M	26.76M	700K	27.67M	4M
Total Liabilities	38.73M	36.06M	43.27M	13.5M	30.86M	8.62M
Total Debt	23.02M	24.54M	25.3M	194K	n/a	4M
Common Stock	59K	46K	42K	41K	1K	1K
Retained Earnings	-237.76M	-168.76M	-110.47M	-47.41M	-14.74M	-7.96M
Comprehensive Income	2.16M	665K	-1.53M	-270K	-21.62M	-4M
Shareholders Equity	1.02B	344.35M	320.74M	366.33M	-14.64M	-7.94M
Total Investments	594.57M	324.82M	275.59M	339.38M	n/a	n/a